Cardiovascular Considerations in the HIV Patient: The Debate Continues

Activity Description & Educational Objectives

In this activity, experts in HIV and cardiovascular disease discuss evaluating cardiovascular risk in individuals with HIV, setting therapeutic targets, and cases in primary and secondary prevention.

Upon completion of this activity, participants should be better able to:

• Evaluate current standards of care for assessing cardiovascular risk in patients with HIV, focusing on the potential impact on HIV-related treatment decisions
• Compare and contrast DHHS and IAS guidelines for the initiation of antiretroviral therapy in patients with HIV based on cardiovascular risk
• Develop and implement strategies to improve the cardiovascular risk profile in patients with HIV, such as appropriate timing and selection of therapy

Target Audience

This activity has been designed to meet the educational needs of infectious disease specialists, primary care physicians, NPs, PAs, nurses, and other clinicians involved in caring for patients with HIV.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Internet
Release and Expiration Dates: August 02, 2012 - August 01, 2013
Time to Complete: 60 minutes

Faculty & Disclosure / Conflict of Interest Policy

In accordance with ACCME requirements, Penn State College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Course Director and Moderator

David A. Wohl, MD
Associate Professor
Department of Medicine
Division of Infectious Diseases
University of North Carolina School of Medicine
Chapel Hill, North Carolina

David A. Wohl, MD, has a financial interest/relationship or affiliation in the form of:

Consultant for Abbott Laboratories; Bristol-Myers Squibb; Gilead; and Tibotec Therapeutics (Janssen Research & Development, LLC).

Grant/Research Support from GlaxoSmithKline and Merck & Co., Inc.

Interviewees

Todd T. Brown, MD, PhD
Associate Professor of Medicine and Epidemiology
Division of Endocrinology & Metabolism
Johns Hopkins University
Baltimore, Maryland

Todd T. Brown, MD, PhD, has a financial interest/relationship or affiliation in the form of:

Consultant for Abbott Laboratories; Bristol-Myers Squibb; EMD Serono, Inc.; and ViiV Healthcare.

Grant/Research Support from GlaxoSmithKline.

Priscilla Hsue, MD
Associate Professor of Medicine
University of California, San Francisco
San Francisco, California

Priscilla Hsue, MD, has a financial interest/relationship or affiliation in the form of:

Grant/Research Support from GlaxoSmithKline.

Medical Director

Annette Wiggins
PVI, PeerView Institute for Medical Education

Annette Wiggins currently has no financial interests/relationships or affiliations in relation to this activity.

Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.

Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.

Sponsorship, Credit & Support

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Penn State College of Medicine and PVI, PeerView Institute for Medical Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Penn State College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Information about CME credit for this activity is available by contacting Penn State at 717-531-6483 or ContinuingEd@hmc.psu.edu. Reference course # G5149-12-T.

This CME activity is jointly sponsored by Penn State College of Medicine and PVI, PeerView Institute for Medical Education.

This activity is supported by educational grants from

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.